Glucagon-like peptide-1 receptor agonists are associated with fewer venous thromboembolic events and limb complications in obese patients with chronic venous insufficiency.
Saved in:
| Title: | Glucagon-like peptide-1 receptor agonists are associated with fewer venous thromboembolic events and limb complications in obese patients with chronic venous insufficiency. |
|---|---|
| Authors: | Micalo L; David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA., Archie M; Department of Surgery, Harbor-UCLA Medical Center, Torrance, CA., Rowe VL; David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA., Adewale AP; David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA., Pham NV; David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA., Li A; Keck School of Medicine of the University of Southern California, Los Angeles, CA., Jimenez JC; David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA. Electronic address: jcjimenez@mednet.ucla.edu. |
| Source: | Journal of vascular surgery. Venous and lymphatic disorders [J Vasc Surg Venous Lymphat Disord] 2026 Jun 20; Vol. 14 (5), pp. 102557. Date of Electronic Publication: 2026 Jun 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101607771 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-3348 (Electronic) Linking ISSN: 2213333X NLM ISO Abbreviation: J Vasc Surg Venous Lymphat Disord Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2213-3348 |
|---|---|
| DOI: | 10.1016/j.jvsv.2026.102557 |
